Colorado BioScience Association Endorses Referendums C & D In Its Summer 2005 Edition of The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the second issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Summer 2005 publication cover Referendums C & D; PR Pharmaceuticals based in Fort Collins; and William W. Cimino, Ph.D., President of Sound Surgical in Louisville. Other topics covered include upcoming CBSA events, executive report, CBSA’s public policy process, regulatory update on compliance as a competitive advantage, and news briefs.
Denver, CO, July 19, 2005 --(PR.com)-- The second issue of “The CBSA FOCUS,” the Colorado BioScience Association’s quarterly newsletter is now available. The announcement is made by Denise Brown, CBSA executive director, who says the Association’s quarterly publication features an endorsement of Referendums C and D to the TABOR amendment, which will be on the Colorado ballot in November.
In keeping with its mission, the newsletter helps further share the many success stories and highlights of Colorado’s medical device and biotechnology industries.
In addition to the article on Referendums C and D, featured articles in the Summer FOCUS issue cover PR Pharmaceuticals based in Fort Collins and William W. Cimino, Ph.D., President of Sound Surgical in Louisville. Other topics covered include upcoming CBSA events, executive report, CBSA’s public policy process, regulatory update on compliance as a competitive advantage, and news briefs. Here’s a sampling of the feature articles and links to the full articles and PDF of the newsletter:
“Referendums C and D: Critical To Colorado’s Bioscience Industry” -- In November, Colorado voters will be asked to approve two ballot questions that address the state's fiscal crisis. These referendums could have a significant impact on the quality of Colorado's workforce and the state's infrastructure, key components of a sustainable climate for the bioscience industry. You can read the FOCUS article about Referendums C & D at http://denverprnewsroom.com/_wsn/page20.html.
“The Executive Team At A Company Called PR Pharmaceuticals (PRP) Has A Knack For Making The Right Moves.” That talent may soon reap huge benefits for millions of patients with diabetes and heart disease. PRP is the result of a 1998 merger between Micrel Limited, an Arizona drug delivery company founded by PRP's CEO Steve Howe, and the Fort Collins based Wildlife Pharmaceuticals. Today PRP is a privately owned company that develops and manufactures innovative sustained release drug delivery technologies for human and animal health. Read the FOCUS article about PR Pharmaceuticals at:
http://publicrelationsnewsroom.com/_wsn/page5.html.
“Taking Flight: From Aerospace Engineer To Medical Technology Entrepreneur, Sound Surgical's Founder Is Ready For Take-Off.” It took leaving the aerospace industry to launch William W. Cimino, Ph.D. on a high-flying career path that engaged both his talent and his passion. “My first loves were always medicine and bio-engineering," he says. "So I made my move.” Fifteen years later, Cimino is chairman and president of Sound Surgical Technologies of Louisville, Colorado. You can read the FOCUS article about Dr. Cimino at http://expert411.com/_wsn/page8.html.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1120750765.pdf.
Links are also available to features included in Spring 2005 “The CBSA FOCUS” on these topics:
1) "Bioscience Execs Upbeat: New Survey Shows Increase In New Product Development" -- http://www.pr.com/upload/presskit_1811_1121365070.pdf
2) McKinley Medical Carves Out a New Niche in Pain Management -- http://www.pr.com/upload/presskit_1811_1121366349.pdf
3) Colorado’s Triple Threat: Dr. Michael R. Bristow Clinician, Researcher and Entrepreneur -- http://www.pr.com/upload/presskit_1811_1121365733.pdf
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (http://www.sagepublicrelations.com) in collaboration with Griff/SMC (http://www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (http://www.pushkinpr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at http://www.cobioscience.com
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
###
In keeping with its mission, the newsletter helps further share the many success stories and highlights of Colorado’s medical device and biotechnology industries.
In addition to the article on Referendums C and D, featured articles in the Summer FOCUS issue cover PR Pharmaceuticals based in Fort Collins and William W. Cimino, Ph.D., President of Sound Surgical in Louisville. Other topics covered include upcoming CBSA events, executive report, CBSA’s public policy process, regulatory update on compliance as a competitive advantage, and news briefs. Here’s a sampling of the feature articles and links to the full articles and PDF of the newsletter:
“Referendums C and D: Critical To Colorado’s Bioscience Industry” -- In November, Colorado voters will be asked to approve two ballot questions that address the state's fiscal crisis. These referendums could have a significant impact on the quality of Colorado's workforce and the state's infrastructure, key components of a sustainable climate for the bioscience industry. You can read the FOCUS article about Referendums C & D at http://denverprnewsroom.com/_wsn/page20.html.
“The Executive Team At A Company Called PR Pharmaceuticals (PRP) Has A Knack For Making The Right Moves.” That talent may soon reap huge benefits for millions of patients with diabetes and heart disease. PRP is the result of a 1998 merger between Micrel Limited, an Arizona drug delivery company founded by PRP's CEO Steve Howe, and the Fort Collins based Wildlife Pharmaceuticals. Today PRP is a privately owned company that develops and manufactures innovative sustained release drug delivery technologies for human and animal health. Read the FOCUS article about PR Pharmaceuticals at:
http://publicrelationsnewsroom.com/_wsn/page5.html.
“Taking Flight: From Aerospace Engineer To Medical Technology Entrepreneur, Sound Surgical's Founder Is Ready For Take-Off.” It took leaving the aerospace industry to launch William W. Cimino, Ph.D. on a high-flying career path that engaged both his talent and his passion. “My first loves were always medicine and bio-engineering," he says. "So I made my move.” Fifteen years later, Cimino is chairman and president of Sound Surgical Technologies of Louisville, Colorado. You can read the FOCUS article about Dr. Cimino at http://expert411.com/_wsn/page8.html.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1120750765.pdf.
Links are also available to features included in Spring 2005 “The CBSA FOCUS” on these topics:
1) "Bioscience Execs Upbeat: New Survey Shows Increase In New Product Development" -- http://www.pr.com/upload/presskit_1811_1121365070.pdf
2) McKinley Medical Carves Out a New Niche in Pain Management -- http://www.pr.com/upload/presskit_1811_1121366349.pdf
3) Colorado’s Triple Threat: Dr. Michael R. Bristow Clinician, Researcher and Entrepreneur -- http://www.pr.com/upload/presskit_1811_1121365733.pdf
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (http://www.sagepublicrelations.com) in collaboration with Griff/SMC (http://www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (http://www.pushkinpr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at http://www.cobioscience.com
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
###
Contact
Colorado BioScience Association
Denise Brown
303.592.4073
http://www.cobioscience.com
Denise Brown
303.592.4073
http://www.cobioscience.com
Contact
Categories